# Ceragem Medisys, Inc.

- Location (FDA's records): Cheonan, Chungcheongnam-Do, KR
- FDA decisions: 4 (2013–2014): 4 510(k) clearances
- Product codes: NBW (3), LFR (1)
- Predicates its devices cite: 4 (2 its own); citations of its devices by later devices: 2 (2 its own)
- Recalls linked to its devices: 0 (0 Class I)
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Firms whose devices it cites most
- Bionime Corporation: 1 (https://510kreport.com/company/bionime)
- Bayer Healthcare, LLC: 1 (https://510kreport.com/company/bayer-healthcare)

## Its most-cited devices
- K102751: Labonacheck Gluppy Blood Glucose Monitoring System (2013), cited by 1
- K131727: Cera-Chek 1070 Blood Glucose Monitoring System (2014), cited by 1

## Recent decisions
- K141829: Glucovitaal H1A Blood Glucose Monitoring System (Sep 24, 2014)
- K140141: Labonacheck Gluppy Blood Glucose Monitoring System (Jul 3, 2014)
- K131727: Cera-Chek 1070 Blood Glucose Monitoring System (Feb 28, 2014)
- K102751: Labonacheck Gluppy Blood Glucose Monitoring System (Feb 11, 2013)

Source page: https://510kreport.com/company/ceragem-medisys